REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company’s request to transfer the listing of the Company’s common stock from The Nasdaq Global Market to The Nasdaq Capital Market, which will take effect with the opening of the market on Wednesday, October 28, 2009. The Company’s securities will continue to trade on The Nasdaq Stock Market (Nasdaq) under the symbol “APPA.”
